HEADER HYDROLASE/HYDROLASE INHIBITOR 20-MAY-11 3S54 TITLE HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG TITLE 2 DARUNAVIR IN SPACE GROUP P21212 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 500-598; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS DARUNAVIR, HIV/AIDS, DRUG RESISTANCE, ASPARTIC PROTEASE, MOLECULAR KEYWDS 2 RECOGNITION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.-F.TIE,Y.-F.WANG,I.T.WEBER REVDAT 2 13-SEP-23 3S54 1 REMARK SEQADV HETSYN LINK REVDAT 1 21-MAR-12 3S54 0 JRNL AUTH Y.TIE,Y.F.WANG,P.I.BOROSS,T.Y.CHIU,A.K.GHOSH,J.TOZSER, JRNL AUTH 2 J.M.LOUIS,R.W.HARRISON,I.T.WEBER JRNL TITL CRITICAL DIFFERENCES IN HIV-1 AND HIV-2 PROTEASE SPECIFICITY JRNL TITL 2 FOR CLINICAL INHIBITORS. JRNL REF PROTEIN SCI. V. 21 339 2012 JRNL REFN ISSN 0961-8368 JRNL PMID 22238126 JRNL DOI 10.1002/PRO.2019 REMARK 2 REMARK 2 RESOLUTION. 1.42 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.42 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.157 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.154 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2030 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 40693 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.146 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.143 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1754 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 35008 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1514 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 161 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1686.3 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1606.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 27 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 17160 REMARK 3 NUMBER OF RESTRAINTS : 24159 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : 0.030 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.052 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.057 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.023 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.003 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.056 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.066 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CONJUGAGE GRADIENT MINIMIZATION REMARK 4 REMARK 4 3S54 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000065772. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45155 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.420 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.42 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.47 REMARK 200 COMPLETENESS FOR SHELL (%) : 49.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.33600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 2IEN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M NACL,0.1M SODIUM ACETATE PH4.6, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.29750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.08050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.29750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.08050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 41 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ARG A 57 CD - NE - CZ ANGL. DEV. = 22.0 DEGREES REMARK 500 ARG B 41 NE - CZ - NH2 ANGL. DEV. = -5.0 DEGREES REMARK 500 ARG B 57 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 501 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 60 O REMARK 620 2 HOH A1002 O 96.1 REMARK 620 3 HOH A1087 O 96.0 91.8 REMARK 620 4 HOH A1088 O 105.0 157.0 77.2 REMARK 620 5 HOH A1097 O 78.2 88.6 174.2 104.4 REMARK 620 6 HOH A1101 O 169.0 75.8 91.8 84.4 93.9 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 512 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 017 B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 511 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 521 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 531 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IEN RELATED DB: PDB REMARK 900 WILD TYPE HIV-1 PROTEASE WITH ANTIVIRAL DRUG DARUNAVIR REMARK 900 RELATED ID: 3EBZ RELATED DB: PDB REMARK 900 WILD TYPE HIV-2 PROTEASE WITH ANTIVIRAL DRUG DARUNAVIR REMARK 900 RELATED ID: 3S43 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG REMARK 900 AMPRENAVIR REMARK 900 RELATED ID: 3S53 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG REMARK 900 DARUNAVIR IN SPACE GROUP P212121 DBREF 3S54 A 1 99 UNP Q7SSI0 Q7SSI0_9HIV1 1 99 DBREF 3S54 B 1 99 UNP Q7SSI0 Q7SSI0_9HIV1 1 99 SEQADV 3S54 LYS A 7 UNP Q7SSI0 GLN 7 ENGINEERED MUTATION SEQADV 3S54 ILE A 32 UNP Q7SSI0 VAL 32 ENGINEERED MUTATION SEQADV 3S54 ILE A 33 UNP Q7SSI0 LEU 33 ENGINEERED MUTATION SEQADV 3S54 VAL A 47 UNP Q7SSI0 ILE 47 ENGINEERED MUTATION SEQADV 3S54 ILE A 63 UNP Q7SSI0 LEU 63 ENGINEERED MUTATION SEQADV 3S54 ALA A 67 UNP Q7SSI0 CYS 67 ENGINEERED MUTATION SEQADV 3S54 ILE A 82 UNP Q7SSI0 VAL 82 ENGINEERED MUTATION SEQADV 3S54 ALA A 95 UNP Q7SSI0 SER 95 ENGINEERED MUTATION SEQADV 3S54 LYS B 7 UNP Q7SSI0 GLN 7 ENGINEERED MUTATION SEQADV 3S54 ILE B 32 UNP Q7SSI0 VAL 32 ENGINEERED MUTATION SEQADV 3S54 ILE B 33 UNP Q7SSI0 LEU 33 ENGINEERED MUTATION SEQADV 3S54 VAL B 47 UNP Q7SSI0 ILE 47 ENGINEERED MUTATION SEQADV 3S54 ILE B 63 UNP Q7SSI0 LEU 63 ENGINEERED MUTATION SEQADV 3S54 ALA B 67 UNP Q7SSI0 CYS 67 ENGINEERED MUTATION SEQADV 3S54 ILE B 82 UNP Q7SSI0 VAL 82 ENGINEERED MUTATION SEQADV 3S54 ALA B 95 UNP Q7SSI0 SER 95 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR ILE ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO ILE ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR ILE ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO ILE ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE HET NA A 501 1 HET CL A 512 1 HET 017 B 201 76 HET CL B 511 1 HET GOL B 521 12 HET ACT B 531 4 HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM 017 (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3- HETNAM 2 017 [[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2- HETNAM 3 017 HYDROXYPROPYLCARBAMATE HETNAM GOL GLYCEROL HETNAM ACT ACETATE ION HETSYN 017 DARUNAVIR; TMC114; UIC-94017 HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NA NA 1+ FORMUL 4 CL 2(CL 1-) FORMUL 5 017 C27 H37 N3 O7 S FORMUL 7 GOL C3 H8 O3 FORMUL 8 ACT C2 H3 O2 1- FORMUL 9 HOH *161(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLN A 92 GLY A 94 5 3 HELIX 3 3 GLY B 86 THR B 91 1 6 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 A 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 B 8 LYS A 43 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 B 8 THR A 31 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N ILE A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N VAL A 11 O ALA A 22 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 8 LYS B 43 GLY B 49 0 SHEET 2 C 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 C 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 C 8 ILE B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 C 8 ILE B 84 ILE B 85 -1 O ILE B 84 N ILE B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 C 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 C 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 LINK O ASP A 60 NA NA A 501 1555 1555 2.41 LINK NA NA A 501 O HOH A1002 1555 1555 2.28 LINK NA NA A 501 O HOH A1087 1555 1555 2.46 LINK NA NA A 501 O HOH A1088 1555 1555 2.18 LINK NA NA A 501 O HOH A1097 1555 1555 2.46 LINK NA NA A 501 O HOH A1101 1555 1555 2.66 SITE 1 AC1 6 ASP A 60 HOH A1002 HOH A1087 HOH A1088 SITE 2 AC1 6 HOH A1097 HOH A1101 SITE 1 AC2 4 THR A 74 ASN A 88 HOH A1155 ARG B 41 SITE 1 AC3 30 ARG A 8 ASP A 25 GLY A 27 ALA A 28 SITE 2 AC3 30 ASP A 29 ASP A 30 ILE A 32 VAL A 47 SITE 3 AC3 30 GLY A 48 GLY A 49 ILE A 50 PRO A 81 SITE 4 AC3 30 ILE A 82 ILE A 84 HOH A1081 LEU B 23 SITE 5 AC3 30 ASP B 25 GLY B 27 ALA B 28 ASP B 29 SITE 6 AC3 30 ASP B 30 ILE B 32 VAL B 47 GLY B 48 SITE 7 AC3 30 GLY B 49 ILE B 50 PRO B 81 ILE B 82 SITE 8 AC3 30 ILE B 84 HOH B1084 SITE 1 AC4 1 TRP B 6 SITE 1 AC5 3 LYS B 55 VAL B 56 ARG B 57 SITE 1 AC6 6 PRO B 39 GLY B 40 ARG B 41 TYR B 59 SITE 2 AC6 6 ASP B 60 HOH B1073 CRYST1 58.595 86.161 46.204 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017066 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011606 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021643 0.00000 CONECT 521 1652 CONECT 1652 521 1747 1787 1788 CONECT 1652 1794 1797 CONECT 1654 1656 CONECT 1655 1657 CONECT 1656 1654 1658 1666 CONECT 1657 1655 1659 1667 CONECT 1658 1656 1660 CONECT 1659 1657 1661 CONECT 1660 1658 1662 CONECT 1661 1659 1663 CONECT 1662 1660 1664 1668 CONECT 1663 1661 1665 1669 CONECT 1664 1662 1666 CONECT 1665 1663 1667 CONECT 1666 1656 1664 CONECT 1667 1657 1665 CONECT 1668 1662 1670 1672 1674 CONECT 1669 1663 1671 1673 1675 CONECT 1670 1668 CONECT 1671 1669 CONECT 1672 1668 CONECT 1673 1669 CONECT 1674 1668 1676 1684 CONECT 1675 1669 1677 1685 CONECT 1676 1674 1678 CONECT 1677 1675 1679 CONECT 1678 1676 1680 1682 CONECT 1679 1677 1681 1683 CONECT 1680 1678 CONECT 1681 1679 CONECT 1682 1678 CONECT 1683 1679 CONECT 1684 1674 1686 CONECT 1685 1675 1687 CONECT 1686 1684 1688 1690 CONECT 1687 1685 1689 1691 CONECT 1688 1686 CONECT 1689 1687 CONECT 1690 1686 1692 1716 CONECT 1691 1687 1693 1717 CONECT 1692 1690 1694 CONECT 1693 1691 1695 CONECT 1694 1692 1696 1698 CONECT 1695 1693 1697 1699 CONECT 1696 1694 CONECT 1697 1695 CONECT 1698 1694 1700 CONECT 1699 1695 1701 CONECT 1700 1698 1702 1714 CONECT 1701 1699 1703 1715 CONECT 1702 1700 1704 CONECT 1703 1701 1705 CONECT 1704 1702 1706 CONECT 1705 1703 1707 CONECT 1706 1704 1708 1714 CONECT 1707 1705 1709 1715 CONECT 1708 1706 1710 CONECT 1709 1707 1711 CONECT 1710 1708 1712 CONECT 1711 1709 1713 CONECT 1712 1710 1714 CONECT 1713 1711 1715 CONECT 1714 1700 1706 1712 CONECT 1715 1701 1707 1713 CONECT 1716 1690 1728 CONECT 1717 1691 1729 CONECT 1718 1720 1728 CONECT 1719 1721 1729 CONECT 1720 1718 1722 CONECT 1721 1719 1723 CONECT 1722 1720 1724 CONECT 1723 1721 1725 CONECT 1724 1722 1726 CONECT 1725 1723 1727 CONECT 1726 1724 1728 CONECT 1727 1725 1729 CONECT 1728 1716 1718 1726 CONECT 1729 1717 1719 1727 CONECT 1731 1733 1735 CONECT 1732 1734 1736 CONECT 1733 1731 CONECT 1734 1732 CONECT 1735 1731 1737 1739 CONECT 1736 1732 1738 1740 CONECT 1737 1735 CONECT 1738 1736 CONECT 1739 1735 1741 CONECT 1740 1736 1742 CONECT 1741 1739 CONECT 1742 1740 CONECT 1743 1744 1745 1746 CONECT 1744 1743 CONECT 1745 1743 CONECT 1746 1743 CONECT 1747 1652 CONECT 1787 1652 CONECT 1788 1652 CONECT 1794 1652 CONECT 1797 1652 MASTER 254 0 6 3 20 0 15 6 1726 2 100 16 END